Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients.
Isabela Maria BertoglioJuliana Miranda de Lucena ValimDanielle DaffreNádia Emi AikawaClovis Artur SilvaEloisa S BonfaMichelle Remião Ugolini LopesPublished in: ACR open rheumatology (2021)
This study provides novel evidence that patients with SLE hospitalized because of COVID-19 have significantly higher risks of death and poor outcomes compared with patients without comorbidities and patients with other comorbidities.
Keyphrases
- poor prognosis
- acute respiratory distress syndrome
- coronavirus disease
- cross sectional
- sars cov
- systemic lupus erythematosus
- end stage renal disease
- long non coding rna
- extracorporeal membrane oxygenation
- ejection fraction
- disease activity
- mechanical ventilation
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- rheumatoid arthritis
- type diabetes
- prognostic factors
- adipose tissue
- respiratory syndrome coronavirus
- climate change
- insulin resistance
- glycemic control